EPIC Program Annual Data Tables 2003-2004: Table IX
Rank by Payment | Drug | Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Number of Claims |
---|---|---|---|---|---|---|
Top 20 Totals | 1,550,111 | $214,167,566 | ||||
Percent of Top 20 Drugs to Total EPIC Payments | 14.4% | 30.8% | ||||
1 | PLAVIX | 75MG | SS | 142,603 | $24,139,333 | 4 |
2 | PREVACID | 30MG | SS | 85,308 | $16,651,281 | 15 |
3 | LIPITOR | 10MG | SS | 169,555 | $16,417,321 | 2 |
4 | FOSAMAX | 70MG | SS | 157,348 | $14,976,376 | 3 |
5 | NEXIUM | 40MG | SS | 75,799 | $14,890,074 | 18 |
6 | LIPITOR | 20MG | SS | 97,203 | $14,303,227 | 11 |
7 | ZOCOR | 20MG | SS | 69,816 | $13,697,847 | 22 |
8 | PROTONIX | 40MG | SS | 99,061 | $13,430,813 | 10 |
9 | CELEBREX | 200MG | SS | 87,296 | $11,322,428 | 14 |
10 | ZOCOR | 40MG | SS | 42,561 | $8,287,740 | 40 |
11 | PRAVACHOL | 40MG | SS | 40,735 | $8,060,613 | 47 |
12 | NORVASC | 5MG | SS | 128,481 | $7,740,313 | 7 |
13 | PROCRIT | 40000 U/ML | BNMS | 4,066 | $7,723,746 | 480 |
14 | NORVASC | 10MG | SS | 87,843 | $7,033,642 | 13 |
15 | ARICEPT | 10MG | SS | 39,782 | $6,531,203 | 49 |
16 | OMEPRAZOLE | 20MG | Gen | 39,697 | $6,454,479 | 50 |
17 | LIPITOR | 40MG | SS | 38,791 | $5,908,489 | 53 |
18 | ACIPHEX | 20MG | SS | 31,492 | $5,891,247 | 71 |
19 | VIOXX | 25MG | SS | 51,144 | $5,471,924 | 32 |
20 | ACTONEL | 35MG | SS | 61,530 | $5,235,470 | 24 |
* Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2003-September 30, 2004) as well as the percentage of the totals they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source'.